Latest Financials News

Maximus Resources Limited has issued a Target's Statement recommending shareholders accept Astral Resources NL's off-market takeover bid, which offers a significant premium and improved liquidity. The offer, valuing Maximus shares at approximately $0.073 each, aims to consolidate gold assets in Western Australia under Astral's larger portfolio.

Far Northern Resources has amended its December 2024 Appendix 5B cash flow report to provide clearer details on investing activities, revealing a net cash outflow and a modest cash balance at quarter-end.

Morphic Ethical Equities Fund Limited reported a robust turnaround with a $2.96 million profit after tax for the half-year ended December 2024, reversing last year’s losses despite no dividends declared.

Citigroup Global Markets Australia has announced a partially franked dividend of AUD 2.15 for COH CitiFirst Instalments, with key dates set for March and April 2025.

Citigroup Global Markets Australia has announced a 45-cent unfranked dividend for its CitiFirst Self-Funding Instalment MINIs, with key dates aligned to CPU ordinary shares. The dividend will reduce outstanding loan amounts for MINI holders, impacting their financial positions.

Noble Helium Limited has announced a sweeping board and executive reshuffle following pressure from major shareholders, signaling a strategic reset aimed at strengthening its financial footing and advancing its Tanzanian helium projects.

Health and Plant Protein Group Limited has dramatically reduced its half-year net loss to $43,000 following the divestment of its macadamia division, though uncertainty lingers over a significant IRS receivable in the US.

Health and Plant Protein Group Limited reported a significantly reduced net loss of $43,000 for the half-year ended December 31, 2024, compared to a $748,000 loss in the prior period, despite no operational revenue following the sale of its macadamia division.

Neurizon Therapeutics reported a sharp rise in half-year losses to $7.28 million but marked significant progress with its lead drug NUZ-001 entering a major ALS clinical trial and securing critical regulatory designations.

Eagle Mountain Mining has completed a significant capital raise through the issue of over 518 million new shares and 129 million options, including a $3 million loan conversion, bolstering its exploration projects in Arizona.

Simonds Group delivered a resilient $13.6 million EBITDA in 1H FY25 amid a soft residential market and announced a strategic acquisition of Dennis Family Homes to fuel future growth.

Simonds Group reported a resilient first half of FY25 with EBITDA growth despite market softness and announced a strategic acquisition to strengthen its market position.